Lupin has launched Atharv Ability, its world-class neuro-rehabilitation center in Naraina Vihar, Delhi, dedicated to delivering comprehensive, outcome-driven, specialized, and multidisciplinary care for adults and children with neurological disabilities - enhancing mobility, improving quality of life, and supporting long-term recovery.
Atharv Ability stands at the forefront of advanced neuro-rehabilitation, combining clinical expertise, technological precision, and personalized care programs to bridge critical treatment gaps across a wide spectrum of conditions - including stroke, traumatic brain injury, spinal cord injury, Parkinson’s disease, multiple sclerosis, and pediatric neurological disorders such as cerebral palsy.
Following the successful launch of its centers in Mumbai in 2023 and Hyderabad in 2024, Atharv Ability’s Delhi facility seeks to expand access to integrated, high-quality neuro-rehabilitation care in a region where such specialized services remain limited.
Lupin is an innovation led transnational pharmaceutical company producing, developing and marketing a wide range of branded and generic formulations, biotechnology products and active pharmaceutical ingredients (APIs) globally.
